0001562180-23-006433.txt : 20230818 0001562180-23-006433.hdr.sgml : 20230818 20230818160338 ACCESSION NUMBER: 0001562180-23-006433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230816 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Agresta Samuel CENTRAL INDEX KEY: 0001748961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 231185848 MAIL ADDRESS: STREET 1: 784 MEMORIAL DR. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-08-16 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001748961 Agresta Samuel 500 TECHNOLOGY SQUARE STE 700 CAMBRIDGE MA 02139 false true false false Chief Medical Officer false Common Stock 2023-08-16 4 M false 311297.00 3.72 A 311297.00 D Common Stock 2023-08-16 4 S false 311297.00 8.25 D 0.00 D Stock Option (right to buy) 3.72 2023-08-16 4 M false 311297.00 0.00 D 2029-09-16 Common Stock 311297.00 0.00 D The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested. /s /Allan Reine, M.D., Attorney-in-Fact 2023-08-18